Literature DB >> 25591597

Impact of risk factors on prevalence of anal HPV infection in women with simultaneous cervical lesion.

J Slama, B Sehnal, L Dusek, T Zima, D Cibula.   

Abstract

UNLABELLED: The aim of our study was to determine the risk factors associated with anal HPV infection in HIV-negative women with high-grade cervical lesion. The study group included 172 "high-risk" women who underwent conization for high-grade cervical intraepithelial lesion or microinvasive cervical cancer (CIN 2+). The control group consisted of 100 "low-risk" women with non-neoplastic gynecologic diseases. All participants completed a questionnaire detailing medical history and sexual risk factors and were subjected to anal and cervical HPV genotyping. Concurrent cervical and anal HPV infections were detected in 42.4% (73/172) women of the study group, and in 8.0% (8/100) of women in the control group, respectively. The subgroup with concurrent HPV infections (n=73) dominated women with CIN 3 and microinvasive cancer and anal HPV 16 infections (n=53). Women with concurrent infections more frequently reported any type of sexual contact with the anus including non-penetrative anal sex (OR 2.62, p=0.008). Reporting >5 lifetime sexual partners (OR 2.43, p=0.041), smoking > 60 cigarettes per week (OR 2.33, p=0.048), and a history of penetrative anal intercourse (OR 3.87, p=0.002) were observed as the significant risk factors in women with multiple concurrent HPV infections. Our data support anal HPV testing and anal Pap smear screening in all women with severe cervical lesions caused by HPV 16 and a history of any sexual contact with the anus, heavy smoking and/or more than 5 lifetime sexual partners. KEYWORDS: anal cancer, cervical intraepithelial neoplasia, HPV, risk factor.

Entities:  

Year:  2015        PMID: 25591597     DOI: 10.4149/neo_2015_037

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  14 in total

1.  Results of the Women's Self-Performed Anal Pap Trial in Human Immunodeficiency Virus-Infected Women.

Authors:  Candice J McNeil; Christina S Kong; Andrew Anglemyer; Vivian Levy; Yvonne Maldonado
Journal:  Sex Transm Dis       Date:  2016-07       Impact factor: 2.830

2.  Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis.

Authors:  Chunqing Lin; Jiri Slama; Paula Gonzalez; Marc T Goodman; Ningshao Xia; Aimée R Kreimer; Ting Wu; Nancy A Hessol; Yurii Shvetsov; Ana P Ortiz; Beatriz Grinsztejn; Anna-Barbara Moscicki; Isabelle Heard; María Del Refugio González Losa; Erna M Kojic; Maarten F Schim van der Loeff; Feixue Wei; Adhemar Longatto-Filho; Zizipho A Mbulawa; Joel M Palefsky; Annette H Sohn; Brenda Y Hernandez; Katina Robison; Steve Simpson; Lois J Conley; Alexandra de Pokomandy; Marianne A B van der Sande; Racheal S Dube Mandishora; Lays P B Volpini; Alessandra Pierangeli; Byron Romero; Timothy Wilkin; Silvia Franceschi; Carmen Hidalgo-Tenorio; Reshmie A Ramautarsing; Ina U Park; Fernanda K Tso; Sheela Godbole; Kathleen W M D'Hauwers; Borek Sehnal; Lynette J Menezes; Sandra A Heráclio; Gary M Clifford
Journal:  Lancet Infect Dis       Date:  2019-06-13       Impact factor: 25.071

3.  Relationship between hWAPL polymorphisms and cervical cancer susceptibility.

Authors:  Li Li; Gen-Long Jiao; Shuang Qin; Qing Xiao
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: Results of a pilot study.

Authors:  Joël Fokom Domgue; Craig Messick; Andrea Milbourne; Ming Guo; Mila P Salcedo; Kristina R Dahlstrom; Elizabeth Y Chiao; Ashish A Deshmukh; Erich M Sturgis; Kathleen M Schmeler
Journal:  Gynecol Oncol       Date:  2019-03-01       Impact factor: 5.482

5.  Perceptions of Anal Cancer Risk Among HIV-Positive and High-Risk HIV-Negative Women.

Authors:  Jessica Wells; Rasheeta Chandler; Lisa Flowers; Sudeshna Paul; Anjali Sharma; Nia Kalifa; Marcia Holstad
Journal:  J Low Genit Tract Dis       Date:  2022-04-01       Impact factor: 1.925

6.  Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).

Authors:  Carmen Hidalgo-Tenorio; Jessica Ramírez-Taboada; Concepción Gil-Anguita; Javier Esquivias; Mohamed Omar-Mohamed-Balgahata; Antonio SamPedro; Miguel Lopez-Ruz; Juan Pasquau
Journal:  AIDS Res Ther       Date:  2017-07-18       Impact factor: 2.250

7.  Evaluation of anal cytology and dysplasia in women with a history of lower genital tract dysplasia and malignancy.

Authors:  Beth Cronin; Amy Bregar; Christine Luis; Steven Schechter; Paul Disilvestro; Latha Pisharodi; C James Sung; Christina Raker; Melissa Clark; Katina Robison
Journal:  Gynecol Oncol       Date:  2016-04-26       Impact factor: 5.482

8.  Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer.

Authors:  Mysore S Veena; Santanu Raychaudhuri; Saroj K Basak; Natarajan Venkatesan; Parameet Kumar; Roopa Biswas; Rita Chakrabarti; Jing Lu; Trent Su; Marcus Gallagher-Jones; Marco Morselli; Haiqing Fu; Matteo Pellegrini; Theodore Goldstein; Mirit I Aladjem; Matthew B Rettig; Sharon P Wilczynski; Daniel Sanghoon Shin; Eri S Srivatsan
Journal:  J Biol Chem       Date:  2020-10-07       Impact factor: 5.157

9.  Epidemiological Investigation and Risk Factors for Cervical Lesions: Cervical Cancer Screening Among Women in Rural Areas of Henan Province China.

Authors:  Qingwei Zhang; Wenyan Xie; Feng Wang; Rong Hong Li; Lina Cui; Huifen Wang; Xiuhong Fu; Jiayu Song
Journal:  Med Sci Monit       Date:  2016-06-01

10.  Involvement of TP53 and TP16 expression in human papillomavirus-associated non-small cell lung cancer.

Authors:  Ming Li; Xiao-Lei Zhang; Fang Deng; Li-Ting Qian; Shui-Ping Meng; Wu-Lin Shan; Bao-Long Wang
Journal:  Oncol Lett       Date:  2016-09-05       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.